Bank of New York Mellon »

Aerovate Therapeutics shares owned by Bank of New York Mellon

Quarter-by-quarter ownership of Aerovate Therapeutics (AVTE) shares owned by Bank of New York Mellon from 13F filings

Historical chart of Bank of New York Mellon investment in Aerovate Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aerovate Therapeutics held by Bank of New York Mellon consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aerovate Therapeutics by Bank of New York Mellon

Quarter filed Position value Share count Share price at filing
2024-03-31 $818k 28k 29.57
2023-12-31 $827k 37k 22.63
2023-09-30 $372k 27k 13.57
2023-06-30 $467k 27k 17.15
2023-03-31 $561k 28k 20.17
2022-12-31 $823k 28k 29.30
2022-09-30 $457k 28k 16.58
2022-06-30 $393k 25k 15.66
2022-03-31 $559k 31k 18.33
2021-12-31 $281k 24k 11.81
2021-09-30 $456k 22k 20.95